Alirocumab lowers LDL-C in homozygous familial hypercholesterolaemia
20 Jul 2020
bởiStephen Padilla
Treatment with alirocumab significantly reduces low-density lipoprotein cholesterol (LDL-C), as well as other elevated atherogenic lipids and lipoproteins, in adults with homozygous familial hypercholesterolaemia (HoFH) at week 12, a study has shown.